JVMCX
Price
$28.69
Change
+$0.24 (+0.84%)
Updated
Dec 11 closing price
Net Assets
24.55B
MVCHX
Price
$30.56
Change
+$0.26 (+0.86%)
Updated
Dec 11 closing price
Net Assets
17.21B
Interact to see
Advertisement

JVMCX vs MVCHX

Header iconJVMCX vs MVCHX Comparison
Open Charts JVMCX vs MVCHXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.69
Change+$0.24 (+0.84%)
VolumeN/A
Net Assets24.55B
MFS Mid Cap Value R3
Price$30.56
Change+$0.26 (+0.86%)
VolumeN/A
Net Assets17.21B
JVMCX vs MVCHX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. MVCHX commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and MVCHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.5B vs. MVCHX (17.2B). MVCHX pays higher dividends than JVMCX: MVCHX (0.83) vs JVMCX (0.00). JVMCX was incepted earlier than MVCHX: JVMCX (14 years) vs MVCHX (21 years). JVMCX (1.86) is less costly to investors than MVCHX (1.00). JVMCX is a more actively managed with annual turnover of: 49.00 vs. MVCHX (27.00). MVCHX has a lower initial minimum investment than JVMCX: MVCHX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -3.40 vs. MVCHX (-4.14). JVMCX (30.02) and MVCHX (28.74) have equivalent 5 years return.
JVMCXMVCHXJVMCX / MVCHX
Total Expense Ratio1.850.99187%
Annual Report Gross Expense Ratio1.861.00186%
Fund Existence14 years21 years-
Gain YTD13.3990.1648,176%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.5B17.2B142%
Annual Yield % from dividends0.000.83-
Returns for 1 year-3.40-4.1482%
Returns for 3 years16.0812.74126%
Returns for 5 years30.0228.74104%
Returns for 10 years47.0875.5862%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSKH69.290.33
+0.48%
GSK PLC ADRHEDGED GSKH
BXMX14.530.01
+0.07%
NUVEEN S&P BUY-WRITE Income FUND
SPAM32.94N/A
N/A
Themes Cybersecurity ETF
NPCT10.36-0.08
-0.77%
Nuveen Core Plus Impact Fund
PCM6.17-0.08
-1.28%
PCM Fund